Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 94

    Lupin gets USFDA nod for generic version of Prozac tablets to treat depressive disorder

    Lupin gets USFDA nod for generic version of Prozac tablets to treat depressive disorder

    Medical Dialogues Bureau17 Aug 2019 9:45 AM IST
    The company has received approval for Fluoxetine Tablets from the US Food and Drug Administration(USFDA) to market its product which is a generic...
    Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month

    Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month

    Medical Dialogues Bureau17 Aug 2019 9:15 AM IST
    Rozlytrek was approved by the U.S. Food and Drug Administration on Thursday to treat certain types of solid tumours, which show rare genetic anomalies...
    Pfizer recalls 2 lots of migraine drug RELPAX over possible microbial contamination

    Pfizer recalls 2 lots of migraine drug RELPAX over possible microbial contamination

    Farhat Nasim17 Aug 2019 9:14 AM IST
    Lots of Pfizer Inc's Relpax were distributed nationwide to wholesalers, retailers, hospitals and healthcare providers in the 50 states and Puerto Rico...
    Morepen Labs Q1 export sale of Atorvastatin Calcium up by 57 percent

    Morepen Labs Q1 export sale of Atorvastatin Calcium up by 57 percent

    Medical Dialogues Bureau17 Aug 2019 9:13 AM IST
    Morepen Labs' export sales in Q1'FY 2019-20 for Montelukast Sodium rose by 210 per cent and that of Atorvastatin Calcium by 57 per cent vis-a-vis the...
    Celgene Inrebic gets USFDA nod for bone marrow cancer treatment

    Celgene Inrebic gets USFDA nod for bone marrow cancer treatment

    Medical Dialogues Bureau17 Aug 2019 9:00 AM IST
    Inrebic was approved based on results from a trial of 289 patients with myelofibrosis where the drug was tested against a placebo.U.S: The U.S. Food...
    Emcure Pharma gets USFDA Warning Letter for Manufacturing Violations at Pune plant

    Emcure Pharma gets USFDA Warning Letter for Manufacturing Violations at Pune plant

    Medical Dialogues Bureau16 Aug 2019 9:45 AM IST
    In the letter, the USFDA said inspectors during February 11-20 this year found significant deviations from standard manufacturing practices at Emcure...
    Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter

    Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter

    Medical Dialogues Bureau16 Aug 2019 9:30 AM IST
    Mumbai: India's largest drugmaker Sun Pharmaceutical Industries Ltd. (Sun Pharma) recently reported a consolidated net profit of Rs 1,387.48 crore...
    Serum Institute to unveil thermostable rotavirus vaccine Rotasiil in 9 countries next year

    Serum Institute to unveil thermostable rotavirus vaccine Rotasiil in 9 countries next year

    Medical Dialogues Bureau16 Aug 2019 9:26 AM IST
    Rotasiil remains stable for up to 30 months at a temperature of 25 degrees Celsius, Serum Institute said in a statement. This helps reduce vaccine...
    Novartis replaces top RnD executives at Avexis unit after test data manipulation

    Novartis replaces top RnD executives at Avexis unit after test data manipulation

    Medical Dialogues Bureau16 Aug 2019 9:25 AM IST
    Avexis' Chief Scientific Officer Brian Kaspar and Senior Vice President of Research and Development Allan Kaspar have not been involved in any...
    UK offers USD 30 million freight contract to maintain drug supply after Brexit

    UK offers USD 30 million freight contract to maintain drug supply after Brexit

    Medical Dialogues Bureau16 Aug 2019 9:00 AM IST
    LONDON: Britain is asking logistics providers to bid for a 25 million pound ($30 million) express freight contract to deliver medicines into the...
    Alembic Pharma gets USFDA approval for Fenofibrate tablets to lower cholesterol

    Alembic Pharma gets USFDA approval for Fenofibrate tablets to lower cholesterol

    Farhat Nasim15 Aug 2019 9:55 AM IST
    The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Fenofibrate tablets...
    Wish to see India excel in pharmaceutical research, says Delhi Deputy CM Manish Sisodia

    Wish to see India excel in pharmaceutical research, says Delhi Deputy CM Manish Sisodia

    Medical Dialogues Bureau15 Aug 2019 9:50 AM IST
    Addressing students of the Delhi Pharmaceutical Sciences and Research University (DPSRU), Pushp Vihar, here, Manish Sisodia said that India is placed...
    PrevNext

    Popular Stories

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Top Pharmacy Courses That Rule the Industry

    Top Pharmacy Courses That Rule the Industry

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok